Gilead Sciences ‘strengthens commitment’ to inflammatory disease with new research site 19-Feb-2024 By Isabel Cameron Gilead Sciences has celebrated the opening of its new research site at the Business Park in Oxford with a ribbon-cutting event.
EMA reminds COVID-19 vaccine manufacturers of safety reporting requirements 16-Aug-2021 By Nick Taylor The European Medicines Agency (EMA) has reminded manufacturers of COVID-19 vaccines of their safety reporting obligations.
